LAVINIA P MIDDLETON to In Situ Hybridization, Fluorescence
This is a "connection" page, showing publications LAVINIA P MIDDLETON has written about In Situ Hybridization, Fluorescence.
Connection Strength
0.280
-
Implementation of American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Recommendations in a tertiary care facility increases HER2 immunohistochemistry and fluorescence in situ hybridization concordance and decreases the number of inconclusive cases. Arch Pathol Lab Med. 2009 May; 133(5):775-80.
Score: 0.232
-
Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene in breast cancer. Am J Clin Pathol. 2003 Mar; 119(3):381-7.
Score: 0.038
-
HER-2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger. Cancer. 2005 Mar 01; 103(5):900-5.
Score: 0.011